Gould Capital »

Biogen Idec shares owned by Gould Capital

Quarter-by-quarter ownership of Biogen Idec (BIIB) shares owned by Gould Capital from 13F filings

Historical chart of Gould Capital investment in Biogen Idec

Tip: Access up to 7 years of quarterly data

All positions including Biogen Idec held by Gould Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Biogen Idec by Gould Capital

Quarter filed Position value Share count Share price at filing
2025-03-31 $411 3 137.00
2024-12-31 $459 3 153.00

More positions owned by Gould Capital

Vanguard Ftse Developed Markets Etf Etf (VEA)
Ishares 3-7 Year Treasury Bond Etf Etf (IEI)
Vanguard Total Bond Market Etf Etf (BND)
Vanguard Total International Bond Etf Etf (BNDX)
Vanguard Ftse Emerging Markets Etf Etf (VWO)
Spdr Gold Shares Etf (GLD)
Microsoft Corp Stock (MSFT)
Apple Stock (AAPL)
Caterpillar Stock (CAT)
Ishares Short Treasury Bond Etf Etf (SHV)
Alphabet Inc Cap Stk Cl C Stock (GOOG)
Berkshire Hathaway Inc Del Cl B Stock (BRK.B)
Verizon Communications Stock (VZ)
Aflac Stock (AFL)
Aes Corp Stock (AES)

View all positions for Gould Capital

Top funds holding Biogen Idec

Vanguard Group
PRIMECAP Management Company
BlackRock
State Street Corporation
Point72 Asset Management
Wellington Management Company
Geode Capital Management
Invesco
Susquehanna International
AQR Capital Management
Legal & General Group
Northern Trust
Millennium Management
Pacer Advisors
Ubs Global Asset Management Americas

View all funds holding Biogen Idec